Release Date: 25/08/14 19:11 Summary: Annual Results 2014 and Annual Report 2014 Price Sensitive: No Download Document 1.74MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%